openPR Logo
Press release

Ebola Treatment Market to Undertake Strapping Growth During 2016-2024

07-12-2017 03:26 PM CET | Health & Medicine

Press release from: Persistence Market Research

Ebola Treatment Market to Undertake Strapping Growth During

Ebola viral infection was first observed in The Democratic Republic of Congo (named after a river called Zaire) in 1976. Ebola is a viral disease which frequently causes lethal haemorrhagic fever in humans. The harmful consequences of Ebola viral infection are that the viruses can be used as potential biological weapon. The symptoms of Ebola viral infection include sudden onset of fever, sore throat, headaches, extreme tiredness, vomiting, skin rash, muscular pain, etc.

Get access to full summary @: http://www.persistencemarketresearch.com/market-research/ebola-treatment-market.asp

Ebola virus causes haemorrhagic fever which may lead to internal or external bleeding. The symptoms appear anywhere from 2 to 21 days after exposure to Ebola, though the average is 8 to 10 days. Diagnostic tests are now being done by ELISA (Antigen-capture enzyme-linked immunosorbent assay), Polymerase Chain Reaction, Virus Location, IgM Elisa and Immunohistochemistry testing. Few vaccines and medical treatments for Ebola are in pipeline and due to the absence of effective treatments, the pharmaceutical companies now have big opportunities in the market globally.

As per WHO, several care rehydration methods are adopted with fluid injection orally and other treatments are also taken care of which improves the survival rate. Top drug companies such as Hemispherx Biopharma, Biochryst Pharmaceuticals, Nano Vircides, Serepata Therapeutics, NewLink Genetics and Mapp Biopharmaceuticals are among the key players in the global Ebola treatment market and are conducting trials on a set of experimental drugs.

The global Ebola treatment market growth is driven by the increasing incidence rates of Ebola viral infection and Ebola outbreaks. As per WHO, U.S. & U.K. governments, availability of different treatment procedures to treat Ebola is expected to drive the Ebola viral disease market growth during the forecast period. The Ebola treatment market also includes therapies for those who already have Ebola, and vaccines to prevent the deadly virus. Various drug companies and regulators in the U.S. are taking a two-pronged approach in finding a way to treat the virus. Approval of vaccines are taking a longer time but when vaccines undergo trials, adoption and availability could be a limiting factor for global Ebola treatment market growth.

On the basis of treatment type, the global Ebola treatment market can be segmented as follows: Vaccine (Under Trials), cAd3-Zebov, rVSV-Zebov, TKMEbola, AVI-7537, HEB, BCRX, NNVC, Drugs (Under Trials), Brincidofovir, ZMapp, Favipiravir, Zoloft, Vascor. On the basis of end user, the global Ebola treatment market can be segmented as follows: Hospitals, 500+ Beds, 250-499 Beds, Less than 250 Beds, Ambulatory Surgery Centres, Specialized Clinics, Army Camps (Veteran Facilities) .

A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/11692

Geographically, the global Ebola treatment market is segmented into five regions, namely North America, Latin America, Europe, Asia Pacific (APAC) and the Middle East and Africa (MEA). Control measures are established in Liberia, Sierra Leone, and Guinea. Previously affected countries are Nigeria, Senegal, Spain, U.S., Mali, U.K. and Italy. Among all regions, MEA are expected to witness a high growth rate over the forecast period owing to the large number of affected population in these regions.

North America is the major contributor to the global Ebola treatment market mainly due to its pharmaceutical companies having hubs in the U.S. & Europe. MEA is recovering from medical crisis and is anticipated to have a positive landscape for the growth of the global Ebola treatment market. A healthy CAGR is projected to be registered in the global Ebola treatment market due to a surge in the number of pharmaceuticals and healthcare initiatives being undertaken globally.

The key players in the global Ebola Treatment market are: Arbutus Biopharma, GlaxoSmithKline, Johnson & Johnson Services, Inc., Hemispherx Biopharma, Inc., BioCryst Pharmaceuticals, Inc., NanoViricides, Inc., NewLink Genetics Corporation, Chimerix, Inc., Sarepta Therapeutics, Mapp Biopharmaceutical, Inc.

To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/11692

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, and applications.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ebola Treatment Market to Undertake Strapping Growth During 2016-2024 here

News-ID: 621553 • Views: 160

More Releases from Persistence Market Research

Automotive Antipinch Power Window Systems Market to Record Stellar CAGR During 2 …
Automotive Antipinch Power Window Systems Market 2022-2030 Over the years, deaths and injuries among children left unattended in motor vehicles have become highly frequent. Most casualties are those of children aged below six years. Injuries in stationary vehicles have received scant attention as compared to motor vehicle crashes. These deaths largely occur due to accidental asphyxiation as a result of the closing of windows. Realizing this, automotive manufacturers have been concentrating
Spandex Market Size from 2021-2031
The global spandex market is estimated to expand at a CAGR of more than 8% over the forecast period of 2022-2031. Growing demand from industries such as medical and textiles is one of the leading driving factors for rising growth and consumption of spandex. Rapidly growing population combined with increased consumer disposable income is expected to drive demand for sports and active wear, resulting in market expansion. Increasing engagement in sporting
The Multilayer Ceramic Capacitor (MLCC) Market to show a fetish for growth in th …
Market Overview Ceramic capacitor is endowed with the alternate layers of ceramic and metal. The ceramic material acts as a dielectric. Demand for these ceramic capacitor is rising owning to increasing usage in approximately all the electronics devices. The growth of new designs of MLCCs with improved bypassing, higher capacitances, decoupling and filtering capabilities is estimated to increase ceramic usage. MLCC designs results are ensuring ever thinner layers: even less than one
The Alopecia Treatment Market to see digitization galore between 2020-2030, reac …
Rising global demand for effective hair loss treatment medications, especially oral drugs, is the prime driver of the global alopecia treatment market. Oral hair loss treatment drugs are gaining immense popularity, as they help in maintaining patient-safety through reduced number of medicine dosages, but with increased drug efficacy. With changing lifestyle along with increase in stress levels among the working class population, cosmeceutical drug manufacturers are focusing on expanding their

All 5 Releases


More Releases for Ebola

Global Ebola Vaccine Market Huge Growth Opportunity between 2020-2025
LP INFORMATION recently released a research report on the Ebola Vaccine market analysis, which studies the Ebola Vaccine's industry coverage, current market competitive status, and market outlook and forecast by 2025. Global "Ebola Vaccine Market 2020-2025" Research Report categorizes the global Ebola Vaccine market by key players, product type, applications and regions,etc. The report also covers the latest industry data, key players analysis, market share, growth
Ebola Vaccine Market Opportunity Analysis, 2018-2026
Ebola virus disease (EVD) causes viral hemorrhagic fever. It is a life threatening disease, which is spread to humans from animals. Direct contact with body fluids of infected person is one of largest causes of spread of this infection. Symptoms of Ebola disease include high fever, vomiting, sore throat, diarrhea, headache and muscular pain, and in few cases, internal or external bleeding. Although, there is no cure for Ebola virus
Ebola Treatment Market: Global Industry Analysis and Forecast 2016 - 2024
Ebola viral infection was first observed in The Democratic Republic of Congo (named after a river called Zaire) in 1976. Ebola is a viral disease which frequently causes lethal haemorrhagic fever in humans. The harmful consequences of Ebola viral infection are that the viruses can be used as potential biological weapon. The symptoms of Ebola viral infection include sudden onset of fever, sore throat, headaches, extreme tiredness, vomiting, skin rash,
2017-2022 Global Ebola Virus Vaccine Industry Forecast Report
ReportsWeb.com has announced the addition of the “Global Ebola Virus Vaccine Market Research Report 2017-2022” The report focuses on global major leading players with information such as company profiles, product picture and specification. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD) , market share and growth rate of Ebola Virus Vaccine in these regions, from 2012 to 2022 (forecast) , covering North America, Europe,
Ebola Virus Vaccine Market & Pipeline Insight
Ebola virus infection, which was previously called Ebola hemorrhagic fever was discovered in 1976. The infection caused due to ebola virus originates from four different strains of ebola virus. These viruses generally are known to affect non-human primates, and are transmitted from wild animals to the humans and among the latter, it is known to spread through human-to-human transmission. The natural hosts of ebola virus are Fruit bats, which
combit Employees Support Ebola Victims and Syrian Refugees
Constance/Germany, 12/02/2014 – Among the numerous reports on crisis regions, those that remain particularly etched in our memory are the images of the critically ill people in West Africa who are infected with Ebola and of the suffering of the Syrian refugees. For that reason, the employees of the software company combit in Constance have decided to help. The fight against the Ebola virus is costly, and the Syrian health